In this study, we designed and optimized a TfR-siCEBPB aptamer conjugate, which was evaluated in a primary liver cancer rat model of DEN-induced cirrhotic HCC and in a secondary liver cancer of metastatic PDAC, in which pancreatic cancer cells were directly implanted into the liver. Here, TFRC is linked to liver cancer.